scispace - formally typeset
R

Robert Müller

Researcher at Leibniz Institute of Photonic Technology

Publications -  60
Citations -  2748

Robert Müller is an academic researcher from Leibniz Institute of Photonic Technology. The author has contributed to research in topics: Magnetic nanoparticles & Nanoparticle. The author has an hindex of 22, co-authored 55 publications receiving 2483 citations. Previous affiliations of Robert Müller include Bundesanstalt für Materialforschung und -prüfung & University of Glasgow.

Papers
More filters
Journal ArticleDOI

A fast method of characterizing HTSC bulk material

TL;DR: In this article, a trapped field measurement technique using pulsed field magnetization and field detection by a Hall-array is described, where the required time of measurement is in the order of a few minutes per sample.
Proceedings ArticleDOI

Formation of a biocompatible protein corona on magnetic nanoparticles

TL;DR: The aim of the experiments is to analyze the formation of the protein corona during in vitro serum incubation and to investigate the biocompatibility of such coated SPIONs.
Proceedings ArticleDOI

Bio-nano composite for remote melting

TL;DR: In this paper, the fabrication of biocompatible composites consisting of magnetite nanoparticles embedded into a matrix of meltable dextran ester is presented which can be softened under an induced alternating magnetic field and may allow in that way a magnetically controlled release application.
Book ChapterDOI

Magnetic Oxide Particles Prepared by Glass Crystallization

TL;DR: In this paper, glass crystallization was used and further developed for preparation of micro-and nano- crystalline particulate oxide media of different compositions and with different properties, which may find applications in high-density magnetic recording devices, in novel ferrofluids, in microwave devices, as initial materials for composites and for biomedical purposes.
Journal ArticleDOI

Studies on the Controlled Release of Drugs from Magnetic Nanobiocomposites

TL;DR: The NBC showed a long-term stability of the incorporated iron oxide particles after incubation in artificial body fluids and reveals the potential of the NBC as a drug carrier.